TUMIATTI, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 6.303
AS - Asia 5.838
EU - Europa 5.284
AF - Africa 452
SA - Sud America 285
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.170
Nazione #
US - Stati Uniti d'America 6.216
IT - Italia 1.878
VN - Vietnam 1.615
CN - Cina 1.550
SG - Singapore 1.437
GB - Regno Unito 979
DE - Germania 508
HK - Hong Kong 435
SE - Svezia 423
UA - Ucraina 295
FR - Francia 286
IN - India 256
RU - Federazione Russa 227
BR - Brasile 183
CI - Costa d'Avorio 156
IE - Irlanda 136
NL - Olanda 131
TG - Togo 106
JP - Giappone 104
KR - Corea 100
ZA - Sudafrica 88
FI - Finlandia 77
EE - Estonia 73
BD - Bangladesh 62
CA - Canada 50
BG - Bulgaria 46
SC - Seychelles 41
PH - Filippine 35
ES - Italia 33
JO - Giordania 33
AR - Argentina 31
ID - Indonesia 31
TH - Thailandia 31
TR - Turchia 29
BE - Belgio 27
EC - Ecuador 27
MX - Messico 27
PL - Polonia 27
TW - Taiwan 27
HR - Croazia 24
CH - Svizzera 20
GR - Grecia 17
IQ - Iraq 17
PK - Pakistan 14
AT - Austria 13
CO - Colombia 11
MA - Marocco 11
CL - Cile 10
CZ - Repubblica Ceca 10
DK - Danimarca 10
IR - Iran 10
NG - Nigeria 10
EG - Egitto 9
SA - Arabia Saudita 9
LB - Libano 8
MY - Malesia 8
RO - Romania 8
TN - Tunisia 8
PE - Perù 6
PY - Paraguay 6
DZ - Algeria 5
ET - Etiopia 5
VE - Venezuela 5
AL - Albania 4
AU - Australia 4
AZ - Azerbaigian 4
HU - Ungheria 4
IL - Israele 4
MT - Malta 4
PT - Portogallo 4
UZ - Uzbekistan 4
BO - Bolivia 3
CR - Costa Rica 3
KE - Kenya 3
LK - Sri Lanka 3
LT - Lituania 3
MD - Moldavia 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
KZ - Kazakistan 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SM - San Marino 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
FK - Isole Falkland (Malvinas) 1
GH - Ghana 1
Totale 18.159
Città #
Singapore 966
Southend 849
Ashburn 586
Fairfield 533
San Jose 415
Ho Chi Minh City 410
Hong Kong 408
Hanoi 382
Chandler 378
Santa Clara 363
Houston 266
Bologna 251
Woodbridge 243
Wilmington 237
Seattle 226
Beijing 206
Princeton 203
Ann Arbor 199
Jacksonville 198
Hefei 197
Cambridge 178
Abidjan 156
Boardman 148
Dublin 136
Los Angeles 113
Lomé 106
Padova 96
Lauterbourg 92
Nanjing 91
Milan 87
Westminster 87
Council Bluffs 85
New York 82
Seoul 78
Tokyo 77
Dallas 75
Rome 70
Haiphong 63
Helsinki 60
Jinan 58
Berlin 57
Da Nang 56
Dong Ket 52
Buffalo 51
Shenyang 48
Saint Petersburg 45
Sofia 45
Guangzhou 43
Medford 42
Redmond 41
Munich 40
Shanghai 40
Cesena 38
Changsha 38
Turin 37
Hebei 36
Amman 33
Mülheim 33
Tianjin 31
Nanchang 30
San Diego 30
São Paulo 30
Biên Hòa 29
Redondo Beach 26
Chicago 25
Hải Dương 25
Yubileyny 25
Brussels 24
Frankfurt am Main 24
Redwood City 24
Rimini 24
Falls Church 23
Palermo 23
San Giorgio di Piano 23
Forlì 22
Mahé 22
Naples 22
Carpi 21
Haikou 21
Hangzhou 21
Phoenix 20
Zhengzhou 20
London 19
Taiyuan 19
Bengaluru 18
Bremen 18
Can Tho 18
Des Moines 18
Genoa 18
Bari 17
Bến Tre 17
Toronto 17
Florence 16
Jiaxing 16
Nha Trang 16
Orem 16
Ravenna 16
San Francisco 16
Amsterdam 15
Bắc Giang 15
Totale 11.119
Nome #
Trasportatori di membrana dei farmaci 890
Integrated analytical approaches for the characterization of Spirulina and Chlorella microalgae 426
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. 402
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer 338
Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities 297
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease 294
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) 287
Progettazione e sintesi di analoghi rigidi di metoctramina nello studio dei recettori muscarinici 239
Bovine Serum Amine Oxidase and Polyamine Analogues: Chemical Synthesis and Biological Evaluation Integrated with Molecular Docking and 3-D QSAR Studies 233
Cytotoxicity of methoctramine and methoctramine-related polyamines. 231
Progettazione e sintesi di poliammine a potenziale attività antitumorale 228
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties 224
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SUSTITUTED NAPHTHALENE IMIDES AND DIIMIDES AS ANTICANCER AGENT 224
Safety issues in nutraceutical exploitation of Chlorella vulgaris, Arthrospira Platensis and Scenedesmus sp. microalgae 209
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment. 206
Progettazione e sintesi di derivati poliamminici per il trattamento della malattia di Alzheimer 202
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery? 196
Structure-activity relationships of novel substituted naphthalene diimides as anticancer agents 194
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds 187
Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors 182
Natural polyamines and synthetic analogs modify the growth and the morphology of Pyrus communis pollen tubes affecting ROS levels and causing cell death 182
Study of the cytotoxic effects of the new synthetic isothiocyanate CM9 and its fullerene derivative on human T-leukemia cells 180
Design, Synthesis, and biological evaluation of naphtalene diimides derivatives as anticancer agent 178
Novel bis(7)-tacrine derivatives as multitarget ligands: focus on anti-cholinesterase and anti-amyloid activities 176
Synthetic polyamines activating autophagy: Effects on cancer cell death 173
Development of an UHPLC-diode arrays detector (DAD) method for the analysis of polydatin in human plasma 171
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and a perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics 170
Macrocyclic naphthalene diimides as G-quadruplex binders 170
NEWLY SYNTHESIZED POLYAMINE DERIVATIVES AS POTENTIAL ANTICANCER AGENTS 169
Design, synthesis, and biological evaluation of substituted naphtalene imides and diimides as anticancer agents 167
Multitarget-directed ligands: Innovative chemical probes and therapeutic tools against Alzheimer's disease 166
Exploiting RNA as a new biomolecular target for synthetic polyamines 165
Phenolic and Antioxidant Characterization of Fruit By-Products for Their Nutraceuticals and Dietary Supplements Valorization under a Circular Bio-Economy Approach 163
Inhibition of Acetylcholinesterase, Beta-Amyloid Aggregation, and NMDA Receptors in Alzheimer's Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush 163
Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent 162
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease 161
Exploring the effects of isothiocyanates on chemotherapeutic drugs 160
Synthesis of Monomeric Derivatives To Probe Memoquin's Bivalent Interactions 159
Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines 157
Progress in acetylcholinesterase inhibitors for Alzheimer's disease: an update 157
Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate. 155
Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment 153
Combined Methodologies for Determining In Vitro Bioavailability of Drugs and Prediction of In Vivo Bioequivalence From Pharmaceutical Oral Formulations 153
Multifunctional Tacrine Derivatives in Alzheimer’s Disease 152
One-molecule-multiple-target strategy: a novel multifunctional molecule designed to block EGF-r and to exert pro-apoptotic effects 151
Preliminary evaluation of the cytotoxicity of naphthalene diimide-polyamine conjugates in human cancer cells 150
Cytotoxicity of Methoctramine and related Spermine analogues 149
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases 149
Heterocyclic inhibitors of AChE acylation and peripheral sites. 148
Integrated analytical approaches for the characterization of nutraceutical bioactives in microalgae 147
Multi-target-directed drug design strategy: quinone derivatives designed to block amyloid-beta aggregation and to exert antioxidant effects 147
Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: Effect of replacing the inner polymethylene chain with cyclic moieties 146
Progress in acetylcholinesterase inhibitors for Alzheimer's disease 143
MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond 143
In vitro and in vivo evaluation of polymethylene tetraamine derivatives as NMDA receptor channel blockers 143
Structure-Activity Relationships of Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone. 4. Futher Investigation on the Inner Spacer. 142
Analytical characterization of commercial microalgae 141
null 141
Multi-Target-Direcetd Ligands as acetylcholinesterase inhibitors and nicotinic modulators for Alzheimer's disease 140
Polymethylene tetraamine backbone as template for the development of biologically active polyamines 139
Synthetic polyamines as potential amine oxidase inhibitors: a preliminary study. 138
Cytotoxicity of methoctramine-related polyamines 137
Methoctramine-related polyamines as antinociceptive agents 136
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases 136
Structure-Activity Relationships of New Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone 135
Methoctramine analogues inhibit responses to capsaicin and protons in rat dorsal root ganglion neurons 135
null 135
Methoctramine analogues inhibit responses to capsaicin in DRG neurons and cloned TRPV1 132
A rational design of new multi-target-directed-ligands for the treatment of Alzheimer's disease 132
From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease 132
Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors 132
Naphthalene diimide-polyamine hybrids as antiproliferative agents: Focus on the architecture of the polyamine chains 132
Recent advances in alpha1-adrenoreceptor antagonists as pharmacological tools and therapeutic agents. 131
Inibitori delle fosfodiesterasi 130
Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy 130
Discovery of multipotent drugs for the teratment of Alzheimer's disease 129
Rational design of multitarget-directed antioxidants: merging memoquin and lipocrine molecular frameworks 128
Multi-Target-Directed Drug Design Strategy: Development of new Naphthalene Diimides Bearing Isothiocyanate Functionality As Anticancer Agents 127
Polyamines analogs and transglutaminase effects on apical growth of the pollen tube 126
Synthetic polyamines: an overview of their multiple biological activities. 126
Design of Experiments and Optimization of Monacolin K Green Extraction from Red Yeast Rice by Ultra-High-Performance Liquid Chromatography 125
Tacrine Derivatives and Alzheimer's Disease 118
Effect of polyamines on the nicotinic ACh receptor 118
Synthetic polyamines as potential amine oxidases inhibitors: a preliminary study 117
Design, synthesis and biological evaluation of new naphtalene diimides bearing isothiocyanate functionality 117
Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration 115
Methoctramine analogues inhibit capsaicin induced currents in dorsal root ganglia and Xenopus oocytes expressing TRPV1 113
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases. 113
Methoctramine effects on nicotinic acetylcholine receptor kinetics 112
Polyamines, their analogs, and transglutaminase effects on apical growth of the pollen tube 112
Exploiting RNA as anticancer target for synthetic polyamines 111
Recent advances in the design and synthesis of prazosin derivatives 111
Synthesis of monomeric derivatives to probe Memoquin bivalent interactions 109
null 107
null 106
Polyamine effects on apical growth of the pollen tube 105
Interactions between new polyamine analogs and bovine serum amine oxidase. 104
null 104
Novel asymmetric naphthalenediimide-polyamines conjugates as anticancer agents. 102
Evaluation of the inhibitory potency of a new series of AChE-inhibitors by using a monolithic AChE-micro-IMER 101
Totale 16.829
Categoria #
all - tutte 49.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.233
Totale 51.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 0 0 0 0 0 0 207
2021/20221.873 109 59 119 134 164 125 53 138 97 193 347 335
2022/20231.891 219 249 89 224 113 119 101 99 334 60 186 98
2023/20241.004 45 112 78 83 83 193 44 88 55 59 86 78
2024/20252.821 152 348 324 213 563 158 195 115 51 114 134 454
2025/20266.103 589 690 518 412 667 310 895 171 1.068 395 210 178
Totale 18.511